Literature DB >> 3359822

Subclinical left ventricular abnormalities in young diabetics.

S Arvan1, K Singal, R Knapp, A Vagnucci.   

Abstract

Twenty young asymptomatic diabetic patients were evaluated for left ventricular dysfunction by determining the radionuclide ejection fraction response to supine bicycle ergometry. The double product at peak exercise (28,743 +/- 3,314 vs 29,007 +/- 3,625, p greater than .05) was not significantly different between the two groups. Seven of 20 diabetics had either no change or a drop in their ejection fraction during exercise while 1 of 20 control subjects had no change in ejection fraction. There was no correlation between the FBS (r = .26) and HbA1c (r = .32) and ejection fraction change during exercise, although those diabetics with LV dysfunction tended to have a higher HbA1c level as compared to diabetics with a normal response (16.8 +/- 3.1 percent vs 12.5 +/- 3.8 percent respectively, p greater than .05). The LV systolic dysfunction in young asymptomatic diabetic subjects does not appear to correlate with the degree of acute or chronic hyperglycemia, and therefore, is not a direct function of the dynamic metabolic state of diabetes.

Entities:  

Mesh:

Year:  1988        PMID: 3359822     DOI: 10.1378/chest.93.5.1031

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  6 in total

1.  Magnetic resonance imaging analysis of cardiac cycle events in diabetic rats: the effect of angiotensin-converting enzyme inhibition.

Authors:  Ahmad I M Al-Shafei; R G Wise; G A Gresham; T A Carpenter; L D Hall; Christopher L H Huang
Journal:  J Physiol       Date:  2002-01-15       Impact factor: 5.182

Review 2.  Diabetic cardiomyopathy: understanding the molecular and cellular basis to progress in diagnosis and treatment.

Authors:  Inês Falcão-Pires; Adelino F Leite-Moreira
Journal:  Heart Fail Rev       Date:  2012-05       Impact factor: 4.214

3.  Is abnormal iodine-123-MIBG kinetics associated with left ventricular dysfunction in patients with diabetes mellitus?

Authors:  T Sugiyama; C Kurata; K Tawarahara; T Nakano
Journal:  J Nucl Cardiol       Date:  2000 Nov-Dec       Impact factor: 5.952

4.  Hyperglycemic and hyperlipidemic conditions alter cardiac cell biomechanical properties.

Authors:  Jarett Michaelson; Venkatesh Hariharan; Hayden Huang
Journal:  Biophys J       Date:  2014-06-03       Impact factor: 4.033

Review 5.  The use of metoprolol CR/XL in the treatment of patients with diabetes and chronic heart failure.

Authors:  Ovidio De Freitas; Oliver Lenz; Alessia Fornoni; Barry J Materson
Journal:  Vasc Health Risk Manag       Date:  2006

6.  Hyperglycemia and hyperlipidemia can induce morphophysiological changes in rat cardiac cell line.

Authors:  Rocío Varela; Inés Rauschert; Gerardo Romanelli; Andrés Alberro; Juan C Benech
Journal:  Biochem Biophys Rep       Date:  2021-04-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.